Accessibility Statement

Our Impact 

We work every day with the goal of growing our business in responsible and sustainable ways that better people’s lives and benefit society.

Our impact starts with the purpose of our business: to create medicines that make life better. We’re committed to expanding equitable access to medicines for more people around the world, and we are working to improve public health for vulnerable people living in areas with limited resources. We further extend our impact by strengthening communities and addressing social issues – like racial justice and education – that matter to our business, employees and society.

And when there’s a health crisis, like COVID-19, Lilly steps up for the common good. Because it’s the right thing to do.

Building on our purpose, we focus our impact efforts on five key areas:

Increase Access to Medicines
Improve Lives and Communities
Empower a Diverse Workforce
Minimize our Environmental Impact
Operate Ethically and Responsibly

Across these areas, we set and measure challenging goals to continually improve what we do – and how we do it. We discuss those goals throughout this section and website. See Lilly’s ESG Report for detailed information about our social impact and environmental, social and governance work.

At the Heart of Our Impact Is Our Purpose.

We unite caring with discovery to create medicines that make life better for people around the world. Over 47 million people count on Lilly medicines each year. In the nearly 150 years we’ve been in business, we’ve developed and delivered trusted medicines that help people get better, feel better and live better.

That’s Why We’re Dedicated to Increasing Access to Medicines.

Too many people, especially the most vulnerable, lack access to the medicines and care they need. Reaching across industry boundaries, we collaborate with leading health organizations, providers, regulators and governments to find new solutions that help address access challenges and strengthen health care systems.

Million People
Improving Access to Quality Health Care
for 30 Million People by 2030
Improving Access to Quality Healthcare for 30 Million People by 2030

We have established a comprehensive goal - Lilly 30x30 - to improve access to quality health care for 30 million people living in communities with limited resources, annually by 2030.

We’re Improving Lives and Communities.

We invest our time, expertise and resources to drive social impact, with a focus on improving health, education and racial justice. We encourage our employees to volunteer and give in ways that advance our purpose and are meaningful to them.

We’re Empowering a Diverse Workforce.

Diversity, equity and inclusion are fundamental to our company strategy. When Lilly people come to work each day, we bring different experiences, perspectives and traditions. Lilly is committed to welcoming, respecting and valuing that which makes each of us unique. As a major employer, we also take action on racial justice issues that affect our employees, business and communities.

We’re Minimizing Our Environmental Impact.

Making medicines requires the use of valuable resources including energy, water and raw materials. We’re committed to continually improving our environmental impact across our product life cycles and supply chain. We have set new sustainability goals to reduce our emissions and waste and to continue using water responsibly and efficiently.

2030 Environmental Goals


Carbon neutral

in our own operations


renewable electricity


full value-chain emissions reporting



waste to landfills from routine operations


of plastic waste for beneficial use, with at least 90% recycled or reused

Integrate sustainability

into product and packaging design


No adverse impact

to water-stressed areas

No adverse impact

from pharmaceuticals in the environment

Everything We Do Starts with Operating Ethically and Responsibly.

It’s who we are. It’s the foundation of how we conduct business and create positive change for people and communities, while reducing our environmental impact. The Lilly family’s core values of integrity, excellence and respect for people have guided us since the beginning, and they remain at the heart of all we do today.



Respect for People

900x442 Lilly YIR 2023

2023 Year in Review

2022 ESG Report

Lilly Cautionary Statement Regarding Forward-Looking Statements

This website contains forward-looking statements that are based on management’s assumptions and expectations at the time the statements were posted, including statements regarding our sustainability targets, goals, commitments and programs and other business plans, initiatives, aspirations and objectives. The words “estimate”, “project”, “intend”, “expect”, “believe”, “target”, “anticipate” and similar expressions are intended to identify forward-looking statements. All such statements are intended to enjoy the protection of the safe harbor for forward-looking statements provided by the Private Securities Litigation Reform Act of 1995, as amended. Actual results may differ materially due to various factors. The company’s sustainability targets, goals, and commitments outlined in this website or elsewhere, as well as its operations, results, business, goals, and strategy may be affected by factors including, but not limited to, the impact of the evolving COVID-19 pandemic (or any other public health threat) and the global response thereto; the significant costs and uncertainties in the pharmaceutical research and development process, including with respect to the timing and process of obtaining regulatory approvals; competitive developments affecting current products and the company’s pipeline; regulatory actions regarding currently marketed products; litigation, investigations, or other similar proceedings involving past, current, or future products or commercial activities as the company is largely self-insured; the impact and outcome of business development transactions and related integration costs; the impact of global macroeconomic conditions, trade disruptions, disputes, unrest, war or other costs or uncertainties related to doing business in foreign jurisdictions; issues with product supply and regulatory approvals stemming from manufacturing difficulties, disruptions or shortages, including as a result of demand, labor shortages, third-party performance or regulatory actions relating to our facilities; and changes or developments in laws and regulations, including health care reform.

For additional information about the factors that affect the company’s business, please see the company’s latest Forms 10-K, 10-Q, and any 8-Ks filed with the Securities and Exchange Commission. The company expressly disclaims any obligation to update forward-looking statements except as required by applicable law.

Find more detail on Lilly’s environmental, social and governance priorities, strategies and operations.